One year in, Germany's Startup Factories face the real test: scaling DeepTech
A year after Germany launched ten university-linked 'Startup Factories' to boost science-based spin-offs, the programme now faces its harder test — turning research into commercially viable, globally competitive companies. Attention is shifting to funding gaps and industrial validation.
A year ago, Germany's federal government selected ten 'Startup Factories' under the EXIST lighthouse competition, bringing together 126 universities and research institutions with 144 business and financing partners. Private partners have committed roughly €110 million, and each factory can draw up to €10 million in federal funding over five years, matched by private investment.
The initiative aims to convert more university research into viable, high-growth technology companies and shorten the journey from lab to market. The ten selected regions reflect Germany's diverse industrial and research strengths: life sciences in Göttingen, Hannover and Braunschweig; engineering and business in Aachen and Cologne; logistics expertise in Hamburg; and a dense industrial base in the Ruhr area. Berlin-Brandenburg contributes a more internationally connected tech ecosystem.
Racing against global rivals
In fields such as artificial intelligence, quantum computing and robotics, Europe is already competing directly with the United States and China, a reality reflected in Germany's high-tech policy agenda. While Germany has strong research institutions, experienced industrial firms and a broad base of small and medium enterprises, it still lacks an efficient mechanism for converting these strengths into companies that can scale quickly and attract capital.
The stakes are underscored by broader economic trends. An EY analysis found that Germany's industrial sector lost around 124,000 jobs in 2025 alone, while an estimated 522,000 people were employed at German startups and scale-ups in 2024.
Funding gap remains the biggest hurdle
A 2026 industry report estimates Europe's annual DeepTech funding shortfall at between €3.43 billion and €20.59 billion, concentrated mostly at the growth stage. Research-based companies often need significant capital long before they have a finished product or steady revenue, creating a so-called 'Valley of Death' between scientific breakthroughs and investable businesses.
Over the coming months, observers say the key questions will be which teams secure paying customers, which pilot projects turn into contracts, which companies raise substantial follow-on funding, and whether firms can scale internationally from Europe without relocating headquarters or intellectual property abroad.
